Mumbai: Gandhar Oil Refinery (India) has reported a healthy year-on-year(YoY) growth in revenue, which rose from ₹1,005.3 crore in Q3 FY25 to ₹ 1,167 this time. Along with this, the Profit After Tax (PAT) increased 68% YoY to ₹34 crore from ₹20.4 crore as the company chose to focus on the high-margin Pharmaceutical, Health-Care and Performance Oil (PHPO) product segment.
In fact, PHPO commanded almost 50% of its 9M revenues for FY25-26, followed by lubricants at 26.80%, PIO at 9.50% and channel partners at 13.70%. The company’s consolidated EBITDA for Q3 FY26 rose to ₹59.1 crore from ₹41.6 crore, a 42% increase.
“We delivered a strong performance in Q3 FY26, supported by sustained domestic demand and our strategic focus on high-margin PHPO products. Despite global macroeconomic headwinds and logistical disruptions, we recorded sequential growth across all major financial indicators. Revenue for the quarter stood at ₹1,167 crore, reflecting a 16% increase year-on-year, while EBITDA rose 42% to ₹59.1 crore and PAT grew 68% to ₹34.3 crore. For the nine-month period, revenue reached ₹3,129.9 crore and EBITDA amounted to ₹170.9 crore, backed by manufacturing sales volumes of 4,09,974 KL, up 10% over last year. PHPO remained the leading contributor, accounting for 50% of total revenue, driven by strong traction in personal care and healthcare applications,” Aslesh Parekh, Joint Managing Director at Gandhar Oil Refinery (India) Ltd, said in a press release.
“Looking ahead, we remain optimistic about domestic demand and expect steady improvement in international logistics, further strengthening our confidence,” he added.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Readers should conduct their own research or consult with a qualified financial advisor before making any investment decisions.
